|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7068 | |
| A61K 31/7072 | |||
| A61P 35/00 |
| (11) | Number of the document | 1491201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04023557.4 |
| Date of filing the European patent application | 1996-06-06 | |
| (97) | Date of publication of the European application | 2004-12-29 |
| (45) | Date of publication and mention of the grant of the patent | 2006-03-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 472210 | 1995-06-07 | US |
| (72) |
Vonborstel, Reid W., US
Bamat, Michael K., US
|
| (73) |
Wellstat Therapeutics Corporation,
930 Clopper Road, Gaithersburg, MD 20878,
US
|
| (54) | Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |
| Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |